JAMA ONCOLOGYжурнал

Статьи, опубликованные в журнале

---

• • 2021 Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non–Small Cell Lung Cancer
  • Horn Leora, Wang Ziping, Wu Gang, Poddubskaya Elena, Mok Tony, Reck Martin, Wakelee Heather, Chiappori Alberto A., Lee Dae Ho, Breder Valeriy, Orlov Sergey, Cicin Irfan, Cheng Ying, Liu Yunpeng, Fan Yun, Whisenant Jennifer G., Zhou Yi, Oertel Vance, Harrow Kim, Liang Chris, Mao Li, Selvaggi Giovanni, Wu Yi-Long
  • в журнале JAMA ONCOLOGY, том 7, № 11, с. 1617 DOI
• • 2021 Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer
  • Jabbour Salma K., Lee Ki Hyeong, Frost Nikolaj, Breder Valeriy, Kowalski Dariusz M., Pollock Theodore, Levchenko Evgeny, Reguart Noemi, Martinez-Marti Alex, Houghton Baerin, Paoli Jean-Baptiste, Safina Sufia, Park Keunchil, Komiya Takefumi, Sanford Amy, Boolell Vishal, Liu Hong, Samkari Ayman, Keller Steven M., Reck Martin
  • в журнале JAMA ONCOLOGY, том 7, № 9, с. 1351 DOI
• • 2020 Global Retinoblastoma Presentation and Analysis by National Income Level
  • Study Group Global Retinoblastoma, Fabian I.D., Abdallah E., Abdullahi S.U., Abdulqader R.A., Adamou Boubacar S., Ademola-Popoola D.S., Adio A., Afshar A.R., Aggarwal P., Aghaji A.E., Ahmad A., Akib M., Al Harby L., Al Ani M.H., Alakbarova A., Portabella S.A., Al-Badri S., Alcasabas A., Al-Dahmash S.A., … Bowman R.
  • в журнале JAMA ONCOLOGY, том 6, № 5, с. 685-695
• 
  • 2020 Global Retinoblastoma Presentation and Analysis by National Income Level
  • Study Group Global Retinoblastoma, Fabian ID, Abdallah E., et al.
  • в журнале JAMA ONCOLOGY, том 6, № 5, с. 685-695 DOI
• 
  • 2020 Global Retinoblastoma Presentation and Analysis by National Income Level
  • Study Group Global Retinoblastoma, в списке авторов, Polyakov V.G., Ushakova T.L.
  • в журнале JAMA ONCOLOGY, том 6, № 5, с. 685-695 DOI
• • 2019 Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
  • Burtness Barbara, Haddad Robert, Dinis José, Trigo José, Yokota Tomoya, de Souza Viana Luciano, Romanov Ilya, Vermorken Jan, Bourhis Jean, Tahara Makoto, Segalla José Getulio Martins, Psyrri Amanda, Vasilevskaya Irina, Nangia Chaitali Singh, Chaves-Conde Manuel, Kiyota Naomi, Homma Akihiro, Holeckova Petra, Campo Josep Maria Del, Asarawala Nirav, Nicolau Ulisses Ribaldo, Rauch Daniel, Even Caroline, Wang Bushi, Gibson Neil, Ehrnrooth Eva, Harrington Kevin, Cohen Ezra E.W.
  • в журнале JAMA ONCOLOGY, том 5, № 8, с. 1170-1180 DOI
• • 2018 Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor–Positive, HER2-Negative Advanced Breast Cancer
  • Jerusalem Guy, de Boer Richard H., Hurvitz Sara, Yardley Denise A., Kovalenko Elena, Ejlertsen Bent, Blau Sibel, Özgüroglu Mustafa, Landherr László, Ewertz Marianne, Taran Tetiana, Fan Jenna, Noel-Baron Florence, Louveau Anne-Laure, Burris Howard
  • в журнале JAMA ONCOLOGY, том 4, № 10, с. 1367-1374 DOI